English | Spanish

Supporting oncology professionals through education

Login Register

The content on this site is intended for healthcare professionals only

Home
News
Journal
Video
elearning
Events
Conferences
About us

Keyword

Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

Latest news
Sign up for news alerts
Submit your news

Explore

Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas

Journal information

Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us

Author information

Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us

Reviewer information

Reviewer guidelines

Memberships

Videos

Recent videos
Sign up

Explore

Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas

Conferences

Latest conferences
Sign up for latest coverage
Submit your event

About ecancer

About ecancer
Our founders
Funding statement
Contact us

Home
News
Journal
Video
elearning
Events
Conferences
About us

Keyword

Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology

+ -

Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

ASCO 2026: Daraxonrasib doubles median overall survival in metastatic pancreatic cancer

ASCO 2026: Daraxonrasib doubles median overall survival in metastatic pancreatic cancer

ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage RET fusion-positive NSCLC

ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage...

ASCO 2026: Potential new targeted treatment option for people with localised high-risk prostate cancer

ASCO 2026: Potential new targeted treatment option for people with localised high-risk prostate cancer

More news +

Videos

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

More videos +

elearning

A multidisciplinary approach to effective management of myelofibrosis

A multidisciplinary approach to effective management of myelofibrosis

Advancing Pharmacovigilance in Kenya

Advancing Pharmacovigilance in Kenya

Urothelial tumours of the urinary tract coding issues

Urothelial tumours of the urinary tract coding issues

More elearning +

Journal

Access to cancer medicines in Kenya: a scoping review of costs, financial toxicity, quality of life and policy impacts

Access to cancer medicines in Kenya: a scoping review of costs, financial toxicity, quality of life...

Cancer disparities: an extensive review

Cancer disparities: an extensive review

Primary intracranial sarcomas in Peruvian children: a high-incidence clinicopathological series from a National Reference Center

Primary intracranial sarcomas in Peruvian children: a high-incidence clinicopathological series...

More articles +

ecancer events

BRCA Testing in Prostate Cancer

BRCA Testing in Prostate Cancer

Pharmacovigilance Education for the oncology community in Africa

Pharmacovigilance Education for the oncology community in Africa

$Hypofractionated Radiotherapy in Practice: Implementation Strategies for Clinical Success$

Hypofractionated Radiotherapy in Practice: Implementation Strategies for Clinical Success

Conferences

Hot Topics in RCC

Hot Topics in RCC

22 Apr 2024

ASCO 2026

29 May 2026

ASCO-GOIS International Webinars

ASCO-GOIS International Webinars

18 Jun 2024

AACR 2026

17 Apr 2026

More events +

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

Contact
Projects
Cookie Policy
Terms of Use
Desktop Site
Privacy Policy

© 2026 ecancer, all rights reserved

UK registered charity number: 1176307